about
Visceral obesity is associated with increased soluble CD163 concentration in men with type 2 diabetes mellitusBasal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic menComplete recovery after severe myxoedema coma complicated by status epilepticus.Similar VLDL-TG storage in visceral and subcutaneous fat in obese and lean women.Effects of exercise on VLDL-triglyceride oxidation and turnoverHLA Associations and Risk of Posttransplant Lymphoproliferative Disorder in a Danish Population-Based Cohort.Attenuated Suppression of Lipolysis Explains Increases in Triglyceride Secretion and Concentration with Basal Insulin Peglispro (BIL) Relative to Insulin Glargine Treatment in Patients with Type 1 Diabetes.Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study.Quantification of adipose tissue insulin sensitivity.Lean body mass, not FFA, predicts VLDL-TG secretion rate in healthy men.Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders.Chronic adrenergic stimulation induces brown adipose tissue differentiation in visceral adipose tissue.Postprandial VLDL-TG metabolism in type 2 diabetes.Lipoprotein lipase activity does not predict very low-density lipoprotein-triglyceride fatty acid oxidation during exercise.Metformin does not Affect Postabsorptive Hepatic Free Fatty Acid Uptake, Oxidation or Resecretion in Humans: A 3-months Placebo Controlled Clinical Trial in Patients with Type 2 Diabetes and Healthy Controls.Comparison of Methods for Analyzing Human Adipose Tissue Macrophage Content.Multiple Neoplasms Simultaneously Diagnosed by Complementary Triple-Tracer PET/CT and 123I-MIBG Scintigraphy.VLDL triglyceride accumulation in skeletal muscle and adipose tissue in type 2 diabetes.How to Measure Adipose Tissue Insulin Sensitivity.Increased VLDL-TG Fatty Acid Storage in Skeletal Muscle in Men With Type 2 Diabetes.Acute changes in lipoprotein subclasses during exercise.Pharmacokinetics following continuous subcutaneous insulin infusion of insulin aspart with or without initial subcutaneous bolus.Basal and insulin-regulated VLDL1 and VLDL2 kinetics in men with type 2 diabetes.Measuring VLDL1-Triglyceride and VLDL2-Triglyceride Kinetics in Men: Effects of Dietary Control on Day-to-Day Variability.Ketone Body Infusion Increases Circulating Erythropoietin and Bone Marrow Glucose UptakePegylated Long-Acting Human Growth Hormone Possesses a Promising Once-Weekly Treatment Profile, and Multiple Dosing Is Well Tolerated in Adult Patients with Growth Hormone DeficiencyBody composition determines direct FFA storage pattern in overweight womenPostprandial VLDL-triacylglycerol secretion is not suppressed in obese type 2 diabetic menIsolated hyperglycaemia does not increase VLDL-triacylglycerol secretion in type 1 diabetic menKinetics and utilization of lipid sources during acute exercise and acipimoxIncreased AQP7 abundance in skeletal muscle from obese men with type 2 diabetesGrowth hormone upregulates ANGPTL4 mRNA and suppresses lipoprotein lipase via fatty acids: Randomized experiments in human individualsAcute Hyperketonemia does not Affect Glucose or Palmitate Uptake in Abdominal Organs or Skeletal MuscleMetformin increases endogenous glucose production in non-diabetic individuals and individuals with recent-onset type 2 diabetesWhey Protein Combined with Low Dietary Fiber Improves Lipid Profile in Subjects with Abdominal Obesity: A Randomized, Controlled Trial[Delayed diagnosis of adrenal crisis]
P50
Q33596529-DE415190-58D5-4AD3-96B2-7A3201921262Q34448831-87533920-66A8-4D8E-ACAC-652A0167BAB1Q35279082-117D4040-B9D2-4D2A-8227-DF2626A84AA6Q35404743-87811B92-682D-490F-BDE2-98C88394E801Q35756428-4FB9650F-8B95-4C3A-BE00-E58AA7507F90Q37097738-3321E3E9-DA2C-4B1C-981B-AA87E04B478DQ38620136-0A221A5F-2F45-41AF-B7AE-E508D7BA9C88Q38691467-A9176DA3-998E-4D58-8D3C-D3BE7C0B8D29Q38807109-517EC43E-3FA0-4150-B329-0279703C44BBQ40860246-C82D9568-35CB-496D-9FA4-5BADD5FF5A3DQ41104002-1108D2F3-9908-470F-90CF-262D2F0344CEQ41728703-5ED124D5-4390-449D-AD41-920647351C1CQ42466133-757C9E1B-FC8A-4FF9-8EA6-1C30A3BAC2D9Q47721744-16C9900A-4681-4F18-9B5A-358B1E218B09Q47972882-FDF00070-5F87-44C4-9053-BD5D62628581Q48098833-09FF1B98-0965-4EBE-9FD5-D7B1896B72E1Q48231878-5170938D-B4C7-4675-A40C-8219BF7672DCQ48940144-B4A17128-EEAE-47B2-8F49-0A1AA2C5CDB4Q50027945-93F07BA4-EC89-4D1C-95F5-537BDA13E5D5Q51270736-AFE8F565-CFEA-42F7-95B9-9A348A14C141Q51297625-D2497914-502A-4E92-82F2-C96C69DD7843Q51333526-B52F191A-9172-474A-946E-040E2D695366Q51403034-13728649-8208-4F77-B839-CDC4A257AA55Q53801131-1B0E71EC-BAAB-47E0-A1EB-E7C2FFC631E5Q54451988-C2A3AB94-C877-4484-B1F2-ED27792511B9Q57456837-B6208A3D-123D-4983-8C5F-EA083C9EBE27Q59315888-2F39E65D-28AA-4F96-9D5C-2BE1846BE5CEQ83912970-8FC8B07C-4CB8-41AD-A88C-0F4E62BAF7EFQ84509340-B68E4B18-D854-419F-9856-D1B60613B839Q85939027-9644287D-1915-4FAE-ACC4-7E1B1AA4BFD0Q88013192-28F438DE-D4FB-4288-9206-419B70BF37FEQ88760624-5D8E8F51-731B-40D1-9170-3E1BCB2DC2F1Q89831736-4FEC457B-D34C-401F-8E2A-7088D2F0B3E1Q90251487-EA42D1C8-C929-4818-ADB5-C48AB4763179Q93047153-AD3D2675-51EA-44FA-8535-521DC849E296Q93126261-7379228A-63F8-4286-AD51-CF2164BBD630Q95523712-56B53FB0-2ACD-4A29-9545-511D71C5D60D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Esben Søndergaard
@ast
Esben Søndergaard
@en
Esben Søndergaard
@es
Esben Søndergaard
@nl
Esben Søndergaard
@sl
type
label
Esben Søndergaard
@ast
Esben Søndergaard
@en
Esben Søndergaard
@es
Esben Søndergaard
@nl
Esben Søndergaard
@sl
prefLabel
Esben Søndergaard
@ast
Esben Søndergaard
@en
Esben Søndergaard
@es
Esben Søndergaard
@nl
Esben Søndergaard
@sl
P106
P31
P496
0000-0001-8041-6994